Caveolin-1 is critical in the proliferative effect of leptin on osteoblasts through the activation of Akt

Zou,Lin; Zhang,Guichun; Liu,Lifeng; Chen,Chen; Cao,Xuecheng; Cai,Jinfang

doi:10.3892/mmr.2016.5461

Caveolin-1 is critical in the proliferative effect of leptin on osteoblasts through the activation of Akt

Authors:
- Lin Zou
- Guichun Zhang
- Lifeng Liu
- Chen Chen
- Xuecheng Cao
- Jinfang Cai
View Affiliations

Affiliations: Department of Traumatic Orthopedic Surgery, The General Hospital of Jinan Military Command, Jinan, Shandong 250031, P.R. China
Published online on: July 1, 2016 https://doi.org/10.3892/mmr.2016.5461
Pages: 1915-1922
Copyright: © Zou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoblasts are critical in bone remodeling and the repair of bone fractures. Leptin is involved in bone metabolism and osteoblast survival through the downstream signaling pathway, however, the exact mechanism of the effect of leptin on osteoblasts remains to be fully elucidated. In the present study, hFOB 1.19 cells were used to observe the effects of leptin on cell proliferation and apoptosis, and to investigate the underlying mechanism. The results confirmed that treatment of hFOB 1.19 cells with leptin significantly induced cell proliferation. Western blot analysis showed that the expression of caveolin‑1 and the activation of Akt in the cells treated with leptin were significantly increased, compared with the control cells. Additionally, inhibiting Akt activation eliminated the effects on cell proliferation induced by leptin. The rates of cell apoptosis and cell cycle distribution were examined using flow cytometry, which revealed a decrease in the apoptotic rate and an increase in the proportion of cells in the S phase. This indicated that leptin was capable of inducing cell proliferation by inhibiting apoptosis and stimulating cell progression to the S phase. Transfection of the cells with caveolin‑1 small interfering RNA showed that the activation of Akt induced by leptin was significantly inhibited. Furthermore, caveolin‑1 knockdown and inhibiting Akt activation eliminated the increased proliferation, increased proportion of cells in the S phase and increased anti‑apoptotic effects induced by leptin. Taken together, the data obtained in the present study demonstrated that caveolin‑1 was critical in the proliferative effect of leptin on osteoblasts via the activation of Akt.

View Figures

View References

1	Sinha MK, Sturis J, Ohannesian J, Magosin S, Stephens T, Heiman ML, Polonsky KS and Caro JF: Ultradian oscillations of leptin secretion in humans. Biochem Biophys Res Commun. 228:733–738. 1996. View Article : Google Scholar : PubMed/NCBI
2	Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155–1161. 1995. View Article : Google Scholar : PubMed/NCBI
3	Zhang J and Wang N: Leptin in chronic kidney disease: A link between hematopoiesis, bone metabolism, and nutrition. Int Urol Nephrol. 46:1169–1174. 2014. View Article : Google Scholar
4	Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO and Drevon CA: Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res. 16:1426–1433. 2001. View Article : Google Scholar : PubMed/NCBI
5	Taichman RS and Hauschka PV: Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation. 16:587–601. 1992. View Article : Google Scholar : PubMed/NCBI
6	Laharrague P, Larrouy D, Fontanilles AM, Truel N, Campfield A, Tenenbaum R, Galitzky J, Corberand JX, Pénicaud L and Casteilla L: High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J. 12:747–752. 1998.PubMed/NCBI
7	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
8	Sebastién-Ochoa A, Fernández-Garcia D, Reyes-García R, Mezquita-Raya P, Rozas-Moreno P, Alonso-Garcia G and Muñoz-Torres M: Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate. Menopause. 19:172–177. 2012. View Article : Google Scholar
9	Lajeunesse D, Pelletier JP and Martel-Pelletier J: Osteoarthritis: A metabolic disease induced by local abnormal leptin activity? Curr Rheumatol Rep. 7:79–81. 2005. View Article : Google Scholar : PubMed/NCBI
10	Lee SW, Park MC, Park YB and Lee SK: Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int. 27:537–540. 2007. View Article : Google Scholar
11	Wu YP, Chen WS, Xu SJ and Zhang N: Osteoporosis as a potential contributor to the bone metastases. Med Hypotheses. 75:514–516. 2010. View Article : Google Scholar : PubMed/NCBI
12	Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM and Karsenty G: Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell. 100:197–207. 2000. View Article : Google Scholar : PubMed/NCBI
13	Bartell SM, Rayalam S, Ambati S, Gaddam DR, Hartzell DL, Hamrick M, She JX, Della-Fera MA and Baile CA: Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res. 26:1710–1720. 2011. View Article : Google Scholar : PubMed/NCBI
14	Neve A, Corrado A and Cantatore FP: Osteoblast physiology in normal and pathological conditions. Cell Tissue Res. 343:289–302. 2011. View Article : Google Scholar
15	Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P and Karsenty G: Leptin regulates bone formation via the sympathetic nervous system. Cell. 111:305–17. 2002. View Article : Google Scholar : PubMed/NCBI
16	Sawada N, Taketani Y, Amizuka N, Ichikawa M, Ogawa C, Nomoto K, Nashiki K, Sato T, Arai H, Isshiki M, et al: Caveolin-1 in extracellular matrix vesicles secreted from osteoblasts. Bone. 41:52–58. 2007. View Article : Google Scholar : PubMed/NCBI
17	Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S and Karmazyn M: Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Ther. 315:1075–1084. 2005. View Article : Google Scholar : PubMed/NCBI
18	Baker N, Zhang G, You Y and Tuan RS: Caveolin-1 regulates proliferation and osteogenic differentiation of human mesenchymal stem cells. J Cell Biochem. 113:3773–3787. 2012. View Article : Google Scholar : PubMed/NCBI
19	Solomon KR, Danciu TE, Adolphson LD, Hecht LE and Hauschka PV: Caveolin-enriched membrane signaling complexes in human and murine osteoblasts. J Bone Miner Res. 15:2380–2390. 2000. View Article : Google Scholar : PubMed/NCBI
20	Hens JR, Wilson KM, Dann P, Chen X, Horowitz MC and Wysolmerski JJ: TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res. 20:1103–1113. 2005. View Article : Google Scholar : PubMed/NCBI
21	Forbes A, Wadehra M, Mareninov S, Morales S, Shimazaki K, Gordon LK and Braun J: The tetraspan protein EMP2 regulates expression of caveolin-1. J Biol Chem. 282:26542–26551. 2007. View Article : Google Scholar : PubMed/NCBI
22	Basu Roy UK, Henkhaus RS, Loupakis F, Cremolini C, Gerner EW and Ignatenko NA: Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis. Int J Cancer. 133:43–57. 2013. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-timequantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Liu GY, Liang QH, Cui RR, Liu Y, Wu SS, Shan PF, Yuan LQ and Liao EY: Leptin promotes the osteoblastic differentiation of vascular smooth muscle cells from female mice by increasing RANKL expression. Endocrinology. 155:558–567. 2014. View Article : Google Scholar
25	Li Z, Shen J, Wu WK, Yu X, Liang J, Qiu G and Liu J: Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways. PLoS One. 7:e531762012. View Article : Google Scholar
26	Beaulieu A, Poncin G, Belaid-Choucair Z, Humblet C, Bogdanovic G, Lognay G, Boniver J and Defresne MP: Leptin reverts pro-apoptotic and antiproliferative effects of α-linolenic acids in BCR-ABL positive leukemic cells: Involvement of PI3K pathway. PLoS One. 6:e256512011. View Article : Google Scholar
27	Lloyd JT, Alley DE, Hawkes WG, Hochberg MC, Waldstein SR and Orwig DL: Body mass index is positively associated with bone mineral density in US older adults. Arch Osteoporos. 9:1752014. View Article : Google Scholar : PubMed/NCBI
28	Frankenberry KA, Somasundar P, McFadden DW and Vona-Davis LC: Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 188:560–565. 2004. View Article : Google Scholar : PubMed/NCBI
29	Tsuchiya T, Shimizu H, Horie T and Mori M: Expression of leptin receptor in lung: Leptin as a growth factor. Eur J Pharmacol. 365:273–279. 1999. View Article : Google Scholar : PubMed/NCBI
30	Gordeladze JO, Drevon CA, Syversen U and Reseland JE: Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem. 85:825–836. 2002. View Article : Google Scholar : PubMed/NCBI
31	Lee YJ, Park JH, Ju SK, You KH, Ko JS and Kim HM: Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett. 528:43–47. 2002. View Article : Google Scholar : PubMed/NCBI
32	Zhang J, Lazarenko OP, Blackburn ML, Badger TM, Ronis MJ and Chen JR: Soy protein isolate down-regulates caveolin-1 expression to suppress osteoblastic cell senescence pathways. FASEB J. 28:3134–3145. 2014. View Article : Google Scholar : PubMed/NCBI
33	Singh P, Peterson TE, Sert-Kuniyoshi FH, Jensen MD and Somers VK: Leptin upregulates caveolin-1 expression: Implications for development of atherosclerosis. Atherosclerosis. 217:499–502. 2011. View Article : Google Scholar
34	Jasmin JF, Mercier I, Sotgia F and Lisanti MP: SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. Trends Endocrinol Metab. 17:150–158. 2006. View Article : Google Scholar : PubMed/NCBI
35	Razani B, Woodman SE and Lisanti MP: Caveolae: From cell biology to animal physiology. Pharmacol Rev. 54:431–467. 2002. View Article : Google Scholar : PubMed/NCBI